EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Metabolic dysregulation in Huntington's disease: Neuronal and glial perspectives

Ching-Pang Chang, Ching-Wen Wu, Yijuang Chern

Neurobiology of Disease · 2024-10 · 201 · 106672

DOI: 10.1016/j.nbd.2024.106672 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neurobiology of Disease, 2024-10. Verfasst von Ching-Pang Chang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan; Biomedical Translation Research Center, Academia Sinica, Taipei, Taiwan; Departmen…. Hauptthemen laut MEDLINE: Huntington Disease, Neuroglia, Neurons. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 211 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Academia Sinica.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by a mutant huntingtin protein with an abnormal CAG/polyQ expansion in the N-terminus of HTT exon 1. HD is characterized by progressive neurodegeneration and metabolic abnormalities, particularly in the brain, which accounts for approximately 20 % of the body's resting metabolic rate. Dysregulation of energy homeostasis in HD includes impaired glucose transporters, abnormal functions of glycolytic enzymes, changes in tricarboxylic acid (TCA) cycle activity and enzyme expression in the basal ganglia and cortical regions of both HD mouse models and HD patients. However, current understanding of brain cell behavior during energy dysregulation and its impact on neuron-glia crosstalk in HD remains limited. This review provides a comprehensive summary of the current understanding of the differences in glucose metabolism between neurons and glial cells in HD and how these differences contribute to disease development compared with normal conditions. We also discuss the potential impact of metabolic shifts on neuron-glia communication in HD. A deeper understanding of these metabolic alterations may reveal potential therapeutic targets for future drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Huntington DiseaseNeurogliaNeuronsHumansAnimalsEnergy MetabolismGlucose

Stichwörter der Autor:innen

CommunicationGlial cellsGlucose metabolismHuntington's disease

Substanzen

Glucose

Autor:innen und Institutionen

  • Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan; Biomedical Translation Research Center, Academia Sinica, Taipei, Taiwan; Department of Physiology, School of Medicine, College of Medicine, Taipei Medic…
  • Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan; Biomedical Translation Research Center, Academia Sinica, Taipei, Taiwan.

Förderung

  • Academia Sinica

Zitieren

APA

Chang, C. P., Wu, C. W., & Chern, Y. (2024). Metabolic dysregulation in Huntington's disease: Neuronal and glial perspectives. Neurobiology of Disease, 201, 106672. https://doi.org/10.1016/j.nbd.2024.106672

Vancouver

Chang CP, Wu CW, Chern Y. Metabolic dysregulation in Huntington's disease: Neuronal and glial perspectives. Neurobiology of Disease. 2024;201:106672. doi:10.1016/j.nbd.2024.106672

BibTeX
@article{Chang2024,
  author = {Chang, Ching-Pang and Wu, Ching-Wen and Chern, Yijuang},
  title = {Metabolic dysregulation in Huntington's disease: Neuronal and glial perspectives},
  journal = {Neurobiology of Disease},
  year = {2024},
  volume = {201},
  pages = {106672},
  doi = {10.1016/j.nbd.2024.106672}
}
Kostenlos starten →